Physician profile
Wei Zhou
NPI 1790715167
$10,324.10
in general payments reported to CMS, 2019-2025
21 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,066 · 2020: $161 · 2021: $1,639 · 2022: $668 · 2023: $1,157 · 2024: $1,462 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,347 · Travel and Lodging: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,347.31 |
| Travel and Lodging | $442.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $4,189.33 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Conformable Thoracic Stent Graft |
| Merck Sharp & Dohme LLC | $1,476.93 | 2019 | |
| Silk Road Medical, INC. | $1,002.61 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Cook Medical LLC | $863.52 | 2019-2025 | Zenith Alpha, Zilver Ptx, Cook |
| Endologix LLC | $408.39 | 2020-2023 | |
| Medtronic, INC. | $391.88 | 2021-2024 | Venaseal, Symplicity G3 |
| Boston Scientific Corporation | $341.73 | 2019-2022 | |
| Penumbra, INC. | $284.66 | 2021-2025 | Indigo System |
| Novo Nordisk INC | $264.38 | 2021-2025 | Wegovy |
| Abbott Laboratories | $238.26 | 2025 | Esprit |
| Amgen INC. | $218.68 | 2023-2025 | Tavneos, Repatha |
| Baxter Healthcare | $124.80 | 2022 | |
| Stryker Corporation | $109.50 | 2025 | Flowtriever |
| Medtronic Vascular, INC. | $102.90 | 2019 | |
| Viz.Ai, INC. | $98.96 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $74.73 | 2019 | |
| Integra Lifesciences Corporation | $49.66 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Janssen Scientific Affairs, LLC | $37.76 | 2021 | |
| Shockwave Medical, INC | $33.55 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Artivion, INC. | $11.87 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.